12 results about "Antihelminthic Agent" patented technology

The present disclosure provides compositions and methods useful for delivering and encapsulating active agents. The compositions can comprise a polymer and a medium chain triglyceride (MCT) that comprises fatty acids having 6 to 12 carbon atoms. The compositions can encapsulate active agents including an antibacterial, a color compound, a fragrance compound, an active pharmaceutical ingredient (API), an over-the-counter (OTC) ingredient, an antioxidant, a flavinoid, an essential oil, or a combination thereof. In particular, the compositions can encapsulate essential oils. These compositions provide for the gradual and controlled release of active agents, particularly essential oils and can be used in a variety of topical products including insect repellents.

This article is a drug sustained-release device made of a rubber molded body into which volatile drugs such as repellents, insecticides, acaricides, fragrances, deodorants, etc. are kneaded, and it slowly releases the kneaded drugs to the outside. This article is placed and used at a desired installation location inside and outside according to the function of the drug. This article has a through-hole that penetrates the article in the vertical direction, and as shown in the reference diagram showing the usage state, it can also be used by passing a string-like object such as a rope for recovery and suspension through the through-hole.

The present invention relates to the use of N-methoxy(phenylethyl)-pyrazole carboxamides for the control of nematodes in agriculture and as antihelminthic agents against endoparasites in animals and humans, as well as compositions comprising such compounds. The present invention 5 further relates to the use of these compounds or compositions for controlling nematodes and / or helminths, in particular for controlling plant parasitic nematodes, and to the use of these compounds in preparing nematicidal and / or antihelminthic compositions.

To provide a control agent that is easily available and can control meloidogyne without adverse effects on crops and workers, and a meloidogyne control method using the same.SOLUTION: The present invention provides a meloidogyne control agent comprising at least one basic amino acid selected from the group consisting of histidine, ornithine, arginine, and lysine, or at least one antioxidant component selected from the group consisting of cysteine, ascorbic acid, glucosamine, and hydroxyphenylacetic acid.SELECTED DRAWING: Figure 2

The present disclosure provides compositions and methods useful for delivering and encapsulating active agents. The compositions can comprise a polymer and a medium chain triglyceride (MCT) that comprises fatty acids having 6 to 12 carbon atoms. The compositions can encapsulate active agents including an antibacterial, a color compound, a fragrance compound, an active pharmaceutical ingredient (API), an over-the-counter (OTC) ingredient, an antioxidant, a flavinoid, an essential oil, or a combination thereof. In particular, the compositions can encapsulate essential oils. These compositions provide for the gradual and controlled release of active agents, particularly essential oils and can be used in a variety of topical products including insect repellents.

The present disclosure provides compositions and methods useful for delivering and encapsulating active agents. The compositions can comprise a polymer and a medium chain triglyceride (MCT) that comprises fatty acids having 6 to 12 carbon atoms. The compositions can encapsulate active agents including an antibacterial, a color compound, a fragrance compound, an active pharmaceutical ingredient (API), an over-the-counter (OTC) ingredient, an antioxidant, a flavinoid, an essential oil, or a combination thereof. In particular, the compositions can encapsulate essential oils. These compositions provide for the gradual and controlled release of active agents, particularly essential oils and can be used in a variety of topical products including insect repellents.

[Solution] The ozone-containing composition according to the present invention contains a volatile oily solvent, a volatile aqueous solvent, and ozone. The concentration of the volatile oily solvent is in the range of 1-99 wt% with reference to the total composition. The concentration of the volatile aqueous solvent is in the range of 1-99 wt% with reference to the total composition. The volatile oily solvent is a volatile lipophilic liquid paraffin having a boiling point of 170 degrees, a volatile lipophilic silicone oil having a boiling point in the range of 170-200 degrees, or a mixture of the volatile liquid paraffin and the volatile silicone oil. The volatile aqueous solvent is a volatile hydrophilic and lipophilic alcohol having a boiling point of not more than 150 degrees, a volatile hydrophilic and lipophilic ketone having a boiling point of not more than 150 degrees, or a mixture of the volatile alcohol and the volatile ketone. The ozone-containing composition according to the present invention is for insecticidal applications, pest repellent applications, or for the decontamination or decomposition of anticancer agents.

The invention relates to a composition for pharmaceutical, veterinary or food use containing at least one alga and / or at least one extract of an alga for oral anthelmintic use, said alga belonging to the order Fucales, the use of such a composition in the preparation of a medicinal product for treating, controlling and preventing endoparasitic infections in a warm-blooded animal or a human being and a method of preparing a medicinal product from such a composition.

This invention provides a method for preparing and applying a long-acting anthelmintic compound microcapsule. The long-acting anthelmintic compound microcapsule is composed of a component containing an anthelmintic drug, white petrolatum, and pollen microcapsules; the anthelmintic drug content is 10-30 wt% of the total weight. Based on a unique supercritical carbon dioxide mixing process, this invention achieves efficient loading of the anthelmintic agent into the pollen microcapsules under mild conditions. This process further utilizes the porous nature of the microcapsules to achieve sustained release of the anthelmintic agent, thereby effectively prolonging the duration of action. Furthermore, thanks to its micron-sized structure, the microcapsule ensures that the anthelmintic component acts only on the body surface, preventing it from penetrating the skin, thus significantly improving the safety of use.

An encapsulated liquid product and method for encapsulating hydrophilic liquid formulation prepared by crosslinking an alginic acid monomer with calcium lactate for use in administering liquid vaccines, attractants, repellents, toxicants, pesticides, and / or biomarkers to wildlife and livestock. The encapsulated liquid product is edible and biodegradable. Formulations can be produced without expensive machinery. Sublingual or buccal delivery of drugs encapsulating liquid products serves a dual purpose of enhancing mucoadhesion for improved uptake as well as containment prior to ingestion by the target organism. The ability to produce formulations without expensive machinery is currently lacking in the encapsulated liquid materials industry.

The application belongs to the technical field of aquaculture, and particularly relates to application of protochloris vulgaris in preparation of products with activity of inhibiting fish parasites. Specifically, the application discloses application of protochloris vulgaris in preparation of products with activity of inhibiting fish parasites and / or reducing infection rate of fish parasites. Protochloris vulgaris has a significant killing effect on fish parasites, can significantly reduce the infection rate of fish to fish parasites, and can promote the growth of fish. The protochloris vulgaris is used to inhibit fish parasites in the application, no chemical drug residue is left, and the problems of drug resistance and environmental pollution caused by existing chemical repellents are effectively solved.

Compositions and methods for treating or reducing the severity or likelihood of occurrence of a parasitic worm or helminth infection in a subject are described. The methods include administering to the subject a therapeutically effective amount of a killed or inactivated recombinant bacterium expressing a crystal protein such as a Bacillus thuringiensis crystal protein (Cry) in the cytosol of the bacterium. The crystal proteins may be full length, truncated, variant, or sub-variant Cry proteins. Examples of crystal proteins include Cry5B, Cry21, Cry14A, Cry6A, and Cry13A. The recombinant bacteria may be treated with an anti-microbial agent before or during administration to a subject.